analyzed 91 patients with WT1 levels >20,000/10 4 ABL at diagnosis and reported that the magnitude of WT1 log reduction after induction chemotherapy provided an independent predictor of relapse in the multivariate analysis, which remained highly significant even when patients were censored at the time of transplantation [ 4 ].
← all excerpts
The Role of Wilms' Tumor Gene (WT1) Expression as a Marker of Minimal Residual Disease in Acute Myeloid Leukemia.
1
—
—